Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas
1983 • 352 citations
Ifosfamide and Doxorubicin in the Treatment of Advanced Leiomyosarcomas of the Uterus: A Gynecologic Oncology Group Study
1996 • 211 citations
Treatment of uterine leiomyosarcoma.
1988 • 154 citations
Phase II trial of ifosfamide and mesna in leiomyosarcoma ofthe uterus: A Gynecologic Oncology Group study
1992 • 150 citations
Leiomyosarcoma of the uterus
1972 • 149 citations
Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group
2002 • 120 citations
Phase II Trial of Paclitaxel in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study
1999 • 85 citations
Chemotherapy of gynecologic cancer
1984 • 66 citations
Prolonged Oral Etoposide in Recurrent or Advanced Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study
1998 • 65 citations
Chemotherapy of Gynecologic Cancer
1991 • 62 citations
Phase II Trial of Topotecan in Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcomas
2000 • 57 citations
Leiomyosarcoma of the uterus: Clinicopathologic study of 21 cases
1985 • 56 citations
Cisplatin as Second-Line Chemotherapy in the Treatment of Advanced or Recurrent Leiomyosarcoma of the Uterus A Phase II Trial of the Gynecologic Oncology Group
1986 • 55 citations
Combination Chemotherapy with Hydroxyurea, Dacarbazine (DTIC), and Etoposide in the Treatment of Uterine Leiomyosarcoma: A Gynecologic Oncology Group Study
1996 • 46 citations
Trimetrexate in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus: A Phase II Study of the Gynecologic Oncology Group
2002 • 44 citations